Huo LF - Search Results

1

AAV-HGFK1 and Ad-p53 cocktail therapy prolongs survival of mice with colon cancer.

Nie B, Shen Z, Wen JB, Wong OG, Hsueh WD, Huo LF, Kung HF, Jiang B, Lin MC. Nie B, et al. Among authors: huo lf. Mol Cancer Ther. 2008 Sep;7(9):2855-65. doi: 10.1158/1535-7163.MCT-08-0366. Mol Cancer Ther. 2008. PMID: 18790766 Free article.

2

Effective melanoma immunotherapy with interleukin-2 delivered by a novel polymeric nanoparticle.

Yao H, Ng SS, Huo LF, Chow BK, Shen Z, Yang M, Sze J, Ko O, Li M, Yue A, Lu LW, Bian XW, Kung HF, Lin MC. Yao H, et al. Among authors: huo lf. Mol Cancer Ther. 2011 Jun;10(6):1082-92. doi: 10.1158/1535-7163.MCT-10-0717. Epub 2011 Apr 25. Mol Cancer Ther. 2011. PMID: 21518728

3

Inhibition of melanoma growth by subcutaneous administration of hTERTC27 viral cocktail in C57BL/6 mice.

Huo L, Yao H, Wang X, Wong GW, Kung HF, Lin MC. Huo L, et al. PLoS One. 2010 Sep 13;5(9):e12705. doi: 10.1371/journal.pone.0012705. PLoS One. 2010. PMID: 20856939 Free PMC article.

4

Gold(III) porphyrin 1a prolongs the survival of melanoma-bearing mice and inhibits angiogenesis.

Lum CT, Huo L, Sun RW, Li M, Kung HF, Che CM, Lin MC. Lum CT, et al. Acta Oncol. 2011 Jun;50(5):719-26. doi: 10.3109/0284186X.2010.537693. Epub 2010 Nov 29. Acta Oncol. 2011. PMID: 21110776

5

Cancer immunotherapy targeting the telomerase reverse transcriptase.

Huo LF, Tang JW, Huang JJ, Huang PT, Huang CF, Kung HF, Lin MC. Huo LF, et al. Cell Mol Immunol. 2006 Feb;3(1):1-11. Cell Mol Immunol. 2006. PMID: 16549043 Free article. Review.

6

Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors.

Song H, Li CW, Labaff AM, Lim SO, Li LY, Kan SF, Chen Y, Zhang K, Lang J, Xie X, Wang Y, Huo LF, Hsu SC, Chen X, Zhao Y, Hung MC. Song H, et al. Among authors: huo lf. Biochem Biophys Res Commun. 2011 Jan 7;404(1):68-73. doi: 10.1016/j.bbrc.2010.11.064. Epub 2010 Nov 19. Biochem Biophys Res Commun. 2011. PMID: 21094134 Free PMC article.

7

Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer.

Xia W, Wei Y, Du Y, Liu J, Chang B, Yu YL, Huo LF, Miller S, Hung MC. Xia W, et al. Among authors: huo lf. Mol Carcinog. 2009 Jul;48(7):610-7. doi: 10.1002/mc.20504. Mol Carcinog. 2009. PMID: 19058255 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters